Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
People channel feed
Biohaven shakes up leadership team as it feels the heat from migraine competitors
4 years ago
Inmate who posed as AbbVie purchasing officer in $3M scam sentenced to 7 more years of prison
4 years ago
Bob Nelsen woos John Maraganore to his first VC post after retiring from Alnylam
4 years ago
As lead drug runs into a wall, Deciphera slims down its pipeline, puts 140 jobs on the chopping block
4 years ago
R&D
GlaxoSmithKline poaches Pfizer's viral vaccines lead in rush to capitalize on future of mRNA
4 years ago
FDA commish nominee's financial disclosures reveal a vast web of industry ties. Will they matter?
4 years ago
FDA+
Q&A: Horizon CEO Tim Walbert goes from C-suite to face of the brand
4 years ago
Pharma
Marketing
Rafael Holdings guts its top leadership, including short-tenured CEO, as cancer fiasco spurs a shakeup
4 years ago
Pfizer on the hunt for a new CFO as Frank D'Amelio retires after nearly 15 years
4 years ago
Out to prove the next big I/O target, Immunitas' chief dealmaker steps up to CEO role
4 years ago
R&D
BioNTech CEO interview: On boosters, the future of Covid-19, and the plan to make and ship the next vaccine in 3 months
4 years ago
Coronavirus
Medidata Solutions co-founder Glen de Vries dies in plane crash
4 years ago
It’s Califf: Biden picks the former FDA commish to head back to the helm
4 years ago
FDA+
Bono invests in biotech? Peptide player is headed to the US — with celebrity investors backing its move
4 years ago
Financing
Fresh off corporate split, bluebird bio plots new hybrid headquarters at Somerville's Assembly Row
4 years ago
Deals
Weeks into first approval, Cara waves goodbye to founding CEO in favor of board member
4 years ago
Tal Zaks' post-Moderna future is now in view as he joins biotech VC blue-chipper OrbiMed
4 years ago
Weeks into CEO shakeup, Mirati bids adieu to a pair of C-suiters with KRAS drug filing around the corner
4 years ago
'I want to be a granddad': Why John Maraganore left and where he (and Alnylam) are going
4 years ago
In a surprise departure, Alnylam's founding CEO John Maraganore is leaving the company — shares crater
4 years ago
Checkmate CEO hits the exit as Art Krieg's crew struggles to warm investors to TLR9 strategy
4 years ago
Exclusive: A year into his role, Ipsen's CBO is on a $3B mission to get the company 'back on the right track'
4 years ago
Pharma
Feds arrest popular Twitter day trader over alleged 'pump and dump' scheme
4 years ago
Harpoon CEO resigns in wake of dwindling market cap and sliding stock price
4 years ago
Pharma
First page
Previous page
51
52
53
54
55
56
57
Next page
Last page